CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 43 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $154,000 | +83.3% | 32,400 | +25.8% | 0.02% | +18.8% |
| Q2 2020 | $84,000 | -92.9% | 25,746 | -88.8% | 0.02% | -94.4% |
| Q1 2020 | $1,175,000 | -22.6% | 229,437 | -31.1% | 0.28% | +11.4% |
| Q4 2019 | $1,518,000 | -46.0% | 332,926 | -27.6% | 0.26% | -49.5% |
| Q3 2019 | $2,812,000 | -11.5% | 459,541 | -11.9% | 0.50% | -5.4% |
| Q2 2019 | $3,178,000 | +14.2% | 521,827 | +4.1% | 0.53% | +6.0% |
| Q1 2019 | $2,782,000 | -24.7% | 501,206 | -23.2% | 0.50% | -35.5% |
| Q4 2018 | $3,695,000 | -59.9% | 652,884 | -25.6% | 0.78% | -45.2% |
| Q3 2018 | $9,215,000 | +4.2% | 877,624 | +10.2% | 1.43% | +1.1% |
| Q2 2018 | $8,840,000 | +28.5% | 796,367 | -7.4% | 1.41% | +67.4% |
| Q1 2018 | $6,880,000 | -3.9% | 860,002 | -1.5% | 0.84% | -2.7% |
| Q4 2017 | $7,158,000 | +47.0% | 872,969 | +11.2% | 0.87% | +38.1% |
| Q3 2017 | $4,869,000 | +19.8% | 785,343 | +16.9% | 0.63% | +11.8% |
| Q2 2017 | $4,064,000 | +47.7% | 671,681 | +29.4% | 0.56% | +40.2% |
| Q1 2017 | $2,751,000 | -34.8% | 518,995 | -16.4% | 0.40% | -38.5% |
| Q4 2016 | $4,222,000 | – | 620,936 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|